OrthoPediatrics’ (KIDS) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of OrthoPediatrics (NASDAQ:KIDS) in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a $42.00 target price on the stock.

Separately, Truist Financial decreased their price objective on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th.

OrthoPediatrics Price Performance

NASDAQ KIDS opened at $25.61 on Wednesday. OrthoPediatrics has a twelve month low of $21.02 and a twelve month high of $35.99. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The stock has a market capitalization of $620.17 million, a PE ratio of -20.82 and a beta of 1.14. The stock has a 50-day simple moving average of $24.39 and a 200 day simple moving average of $25.94.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.04. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. The firm had revenue of $52.67 million during the quarter, compared to analysts’ expectations of $51.16 million. During the same quarter in the prior year, the firm posted ($0.23) EPS. Research analysts anticipate that OrthoPediatrics will post -0.93 EPS for the current year.

Institutional Investors Weigh In On OrthoPediatrics

Hedge funds and other institutional investors have recently made changes to their positions in the business. Millennium Management LLC acquired a new position in OrthoPediatrics during the fourth quarter valued at approximately $9,798,000. Point72 Asset Management L.P. bought a new stake in shares of OrthoPediatrics during the fourth quarter worth $7,450,000. Wasatch Advisors LP grew its stake in shares of OrthoPediatrics by 47.2% during the fourth quarter. Wasatch Advisors LP now owns 696,318 shares of the company’s stock worth $16,141,000 after buying an additional 223,217 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of OrthoPediatrics by 20.2% during the fourth quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company’s stock worth $24,601,000 after buying an additional 178,078 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of OrthoPediatrics by 29.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock worth $15,576,000 after buying an additional 152,681 shares during the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.